Discover Oncology Journal Citation Rate 2026
2730-6011
Springer Nature
US
Q2 Quartile Open Access
About Discover Oncology
Discover Oncology (DO) is a peer-reviewed academic journal covering Cancer Immunotherapy and Biomarkers and Cancer-related molecular mechanisms research, published by Springer Nature in US, catalogued under ISSN 2730-6011. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.83 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $1067 USD.
Discover Oncology Citation Rate 2026 — In Context
Discover Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 1.83, placing it in the Q2 quartile within the Cancer Immunotherapy and Biomarkers research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Discover Oncology makes all articles freely available to readers for an Article Processing Charge of approximately $1067 USD.
Researchers looking to publish in Discover Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Discover Oncology against similar journals in the field, use our journal comparison tool.
Submission Tips for Discover Oncology
- Budget $1067 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Discover Oncology Compares
Compared against 14 journals in the same research areas.
| ISSN (Print) | 2730-6011 |
|---|---|
| Publisher | Springer Nature |
| Country | United States |
| APC / Cost | $1067 USD |
In-depth profile & metrics
Discover Oncology is published by Springer Nature and based in United States. It publishes open access with an article-processing charge of USD 1067.
In our subject taxonomy, Discover Oncology is classified under Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis and Immune cells in cancer.
Discover Oncology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 1.826.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Discover Oncology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.826 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
First reported case in Brazil of intraventricular pilocytic astrocytoma in an adult patient with literature review
Nathalia Bacci Castilho, Karen Christine Silva, Carlos Tadeu Parisi de Oliveira • 2026
-
Hypomethylation of FAM83A in lung adenocarcinoma mirrors an epigenetic signature of airway cell differentiation states
Camille Wangermez, Francois M. Carlier, Marylène Lecocq • 2026
Compare Journals
Compare Discover Oncology against similar publications in its field:
Related Journals in Your Field
-
Journal of Experimental & Clinical Cancer Research BioMed Central IF 10.31
-
Cancer Biology & Therapy Taylor & Francis IF 6.11
-
JCI Insight American Society for Clinical Investigation IF 5.03
-
BMJ Oncology BMJ IF 4.52
-
Inflammation Springer Science+Business Media IF 4.16
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S4210213696
Get weekly updates for Cancer Immunotherapy and Biomarkers journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.